期刊文献+

MRI影像组学在乳腺癌临床诊疗的研究进展

Research progress of MRI-based radiomics in clinical diagnosis and treatment of breast cancer
下载PDF
导出
摘要 乳腺癌是女性发病率最高的恶性肿瘤,也是全世界女性因恶性肿瘤死亡的主要原因。影像组学能快速、高效地将医学图像信息转化为可量化的影像学数据,定量地分析肿瘤内部生物学信息,评估整个肿瘤的异质性。全文简要阐述影像组学,并基于磁共振成像(MRI)影像组学在乳腺癌的诊断、受体表达及分子分型、疗效评价、复发预测等方面的研究进展予以综述。 Breast cancer is the highest incidence of malignant tumor in women,and it is also the main cause of death of malignant tumor in women all over the world.Radiomics can quickly and efficiently transform medical image information into quantifiable imaging data,quantitatively analyze the internal biological information of tumor,and evaluate the heterogeneity of the whole tumor.This paper briefly describes radiomics,and reviews the research progress of MRI-based radiomics in breast cancer diagnosis,receptor expression and molecular classification,curative effect evaluation,recurrence prediction and so on.
作者 王勤 屈玉婷 李长禄 岑永义 黄德尤 WANG Qin;QU Yuting;LI Changlu;CEN Yongyi;HUANG Deyou(Graduate School,Youjiang Medical University for Nationalities,Baise,Guangxi 533000,China;Department of Radiology,Affiliated Hospital of Youjiang Medical University for Nationalities,Baise,Guangxi 533000,China)
出处 《影像研究与医学应用》 2024年第23期13-16,共4页 Journal of Imaging Research and Medical Applications
关键词 乳腺癌 磁共振成像 影像组学 诊断 预后 Breast cancer Magnetic resonance imaging Radiomics Diagnosis Prognosis
  • 相关文献

参考文献12

二级参考文献105

  • 1高微波,邓鹏飞,杨全新,何拓,李晓会,王琳,陈吉新,贺心畋,陈欣.基于DCE-MRI影像组学鉴别乳腺良恶性肿块的可行性研究[J].临床放射学杂志,2020,39(4):674-679. 被引量:12
  • 2Hornherger J. Cosier LE, Lyman GH. Economic analvsis of targeting chemotherapy using a 21-gene RT-PCPt assay in lymph node negative, estrogen receptor positive, early stage breast cancer [J]. . Am J Manag Care, 2005,11:313-324.
  • 3Kondo M. Hoshi SL. Ishiguro H. et al. Economic evaluation of 21-gene reverse transcriptase polymerase ehain reaction assay in lymph node negative, estrogen receptor positive, early stage breast cancer in Japan [J]. Breast Cancer Res Treat. 2008,112:175-187.
  • 4Paik S, Shak S, Tang G, et al. A multigene assay to prediet recurrence of tamoxifen treated, node negative breast cancer [J]. N Engl J Med. 2004, 351:2817-2826.
  • 5Cronin M. Sangli C, Liu ML, et al. Analytical validation of the Oncotype DX genomie diagnostic test for recurrence prognosis and therapeutie response prediction in node-negative. estrogen receptor positive breast cancer [J]. Clin Chem. 2007, 53:1084-1091.
  • 6Paik S. Development and clinical utility of a 21-gene recurrence seore prognostic assay in patients with early breast cancer treated with tamoxifen [ J ] . Oncologist, 2007, 12:631-635.
  • 7Paik S, Tang G, Shak S, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor positive breast cancer [ J ] . J Clin Oncol, 2006, 24:3726- 3734.
  • 8Wolf I, Ben-Baruch N, Shapira-Frommer R, et al. Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients: a population-based study [ J ] . Cancer, 2008, 112:731-736.
  • 9Bryant J. Oneotype Dx correlates more closely with prognosis than adjuvant online [ C ] . Presented at the 9th International Conference on Primary Therapy of Early Breast Cancer, January 26-29, 2005, St Gallen, Switzerland.
  • 10Habel LA, Shak S, Jacobs MK, et al. A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients [J]. Breast Cancer Res, 2006, 8:R25.

共引文献319

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部